BURGALASSI, SUSI
 Distribuzione geografica
Continente #
NA - Nord America 12.318
EU - Europa 5.891
AS - Asia 5.683
SA - Sud America 790
AF - Africa 270
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.970
Nazione #
US - Stati Uniti d'America 11.963
IT - Italia 2.388
CN - Cina 1.940
SG - Singapore 1.437
HK - Hong Kong 1.052
SE - Svezia 947
BR - Brasile 674
DE - Germania 579
BG - Bulgaria 456
CA - Canada 317
VN - Vietnam 295
GB - Regno Unito 284
UA - Ucraina 271
TR - Turchia 270
RU - Federazione Russa 236
FI - Finlandia 217
KR - Corea 215
IN - India 176
CH - Svizzera 112
FR - Francia 106
CI - Costa d'Avorio 94
AT - Austria 66
NG - Nigeria 61
JP - Giappone 58
BE - Belgio 39
IQ - Iraq 39
PL - Polonia 36
BD - Bangladesh 34
ES - Italia 31
AR - Argentina 30
ID - Indonesia 29
NL - Olanda 27
EG - Egitto 23
ZA - Sudafrica 23
CZ - Repubblica Ceca 21
SN - Senegal 21
PK - Pakistan 18
VE - Venezuela 18
MX - Messico 17
EC - Ecuador 15
GR - Grecia 15
UZ - Uzbekistan 15
CL - Cile 14
AE - Emirati Arabi Uniti 11
IE - Irlanda 11
IR - Iran 11
PE - Perù 11
TN - Tunisia 11
BJ - Benin 10
PH - Filippine 10
PY - Paraguay 10
SA - Arabia Saudita 10
CO - Colombia 9
PT - Portogallo 9
AU - Australia 8
DK - Danimarca 8
MA - Marocco 8
MY - Malesia 8
JO - Giordania 7
KE - Kenya 7
LT - Lituania 7
IL - Israele 6
NP - Nepal 6
UY - Uruguay 6
AZ - Azerbaigian 5
LB - Libano 5
PA - Panama 5
RO - Romania 5
RS - Serbia 5
DZ - Algeria 4
EU - Europa 4
JM - Giamaica 4
TH - Thailandia 4
TW - Taiwan 4
BY - Bielorussia 3
CR - Costa Rica 3
ET - Etiopia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
AO - Angola 2
BN - Brunei Darussalam 2
BO - Bolivia 2
GE - Georgia 2
MN - Mongolia 2
OM - Oman 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BS - Bahamas 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GF - Guiana Francese 1
GN - Guinea 1
Totale 24.958
Città #
Woodbridge 1.365
Ann Arbor 1.237
Ashburn 1.071
Hong Kong 1.038
Singapore 892
Chandler 872
Santa Clara 804
Fairfield 733
Houston 711
Serra 704
Dallas 601
Milan 463
Sofia 456
Beijing 437
Shanghai 363
Jacksonville 344
New York 285
Ottawa 282
Wilmington 281
Seattle 277
Cambridge 258
Hefei 215
Princeton 210
Boardman 209
Seoul 196
Nanjing 183
Lawrence 181
Izmir 171
Medford 155
Los Angeles 152
Des Moines 136
Grafing 120
Bern 107
Dong Ket 107
Abidjan 94
Istanbul 80
Munich 76
Dearborn 75
Redondo Beach 75
Pisa 70
Redwood City 67
Buffalo 64
Rome 63
Lagos 59
Vienna 58
Lucca 54
Frankfurt am Main 52
Council Bluffs 51
Jüchen 51
London 50
Nanchang 50
San Diego 50
São Paulo 50
Ho Chi Minh City 46
Lancaster 46
The Dalles 42
Columbus 40
Pune 38
Pontedera 37
Ogden 36
Tokyo 36
Livorno 35
Bremen 33
Brussels 33
Changsha 33
Kunming 33
Turku 33
Warsaw 32
Boulder 31
Chicago 29
Marseille 29
Hebei 28
Florence 27
Shenyang 27
Belo Horizonte 26
Tianjin 26
Alessandria 25
Fuzhou 24
Falls Church 23
Dakar 21
Norwalk 21
Rio de Janeiro 21
Jakarta 20
Guangzhou 19
Hanoi 17
Orange 17
Washington 17
Brno 16
Chennai 15
Hangzhou 15
Jiaxing 15
Quanzhou 15
Viareggio 15
Auburn Hills 14
Jinan 14
Phoenix 14
Tashkent 14
Baghdad 13
Brasília 12
Cascina 12
Totale 17.990
Nome #
Development and validation of high-performance liquid chromatography method to quantify tavaborole during in vitro transungual permeation studies 259
A water-soluble, mucoadhesive quaternary ammonium chitosan-methyl-β-cyclodextrin conjugate forming inclusion complexes with dexamethasone 245
PREPARATION AND EVALUATION IN RABBITS OF TOPICAL SOLUTIONS CONTAINING FORSKOLIN 225
Liposomes as a potential ocular delivery system of distamycin A 219
Hydrogels for ocular delivery of pilocarpine: Preliminary evaluation in rabbits of the influence of viscosity and of drug solubility 216
Ionic liquids as potential enhancers for transdermal drug delivery 212
Ciclopirox and efinaconazole transungual permeation, antifungal activity, and proficiency to induce resistance in Trichophyton rubrum 203
Arabinogalactan as active compound in the management of corneal wounds: In vitro toxicity and in vivo investigations on rabbits 200
Ciclopirox Hydroxypropyl Chitosan (CPX‐HPCH) Nail Lacquer and Breathable Cosmetic Nail Polish: In Vitro Evaluation of Drug Transungual Permeation Following the Combined Application 194
Development of an HPLC/UV assay for the evaluation of inhibitors of human recombinant monoacylglycerol lipase 190
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma 189
In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer 184
Aloe vera as ophthalmic drug delivery: preliminary evaluation 181
Effects of chitosan and of its N-trimethyl and N-carboxymethyl derivatives on the ocular pharmacokinetics of ofloxacin in rabbits 178
Skin permeation and distribution of two sunscreens: a comparison between reconstituted human skin and hairless rat skin 178
4-Methylbenzylidene camphor microspheres: Reconstituted epidermis (Skinethic®) permeation and distribution 176
Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits 176
Development and in vitro in vivo testing of mucoadhesive buccal patches releasing benzydamine and lidocaine 173
Eel skin as a model surface for mucoadhesion studies 172
Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation 172
A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome 172
Gel-forming erodible inserts for ocular controlled delivery of ofloxacin 171
Arabinogalactan: a new ophthalmic vehicle for dry eye protection and treatment of corneal lesions 170
Carrier tests to assess the effective sporicidal concentration of a liquid chemical disinfectant for a sanitization program. 170
pH-responsive nanostructures based on surface active fatty acid-protic ionic liquids for imiquimod delivery in skin cancer topical therapy 169
Hot-melt extrusion technique (HME) to develop intravitreal inserts 168
Optimization of skin permeation and distribution of ibuprofen by using nanostructures (coagels) based on alkyl vitamin C derivatives 167
Prolonged, contemporaneous administration of pilocarpine and timolol increases the aqueous humor pilocarpine levels in rabbits 166
Effect of 5-oxo-2-pyrrolidinecarboxylic acid (PCA) as a new topically applied agent for dry eye syndrome treatment 166
Rufloxacin eyedrops: effect of different formulations on ocular pharmacokinetics in rabbits 165
Healing of rabbits' cornea following laser welding: effect of solid and semisolid formulations containing indocyanine green 165
Arabinogalattano per uso oculare: caratterizzazione ed efficacia nel processo di riepitelizzazione corneale. 164
A collaborative evaluation of the cytotoxicity of two surfactants by using the human corneal epithelial cell line and the WST-1 test 164
Niaouli oils from different sources: analysis and influence on cutaneous permeation of estradiol in vitro 164
Ophthalmic composition containing mucoadhesive polysaccharides able to promote corneal re-epithelization 163
Poloxamer 407 microspheres for orotransmucosal drug delivery. Part II: In vitro/in vivo evaluation 162
Topical Formulations Containing Finasteride. Part II: Determination of Finasteride Penetration into Hair Follicles using the Differential Stripping Technique 161
Ciclopirox vs amorolfine: in vitro penetration into and permeation through human healthy nails of commercial nail lacquers 161
null 160
Development of a Simple Dry Eye Model in the Albino Rabbit and Evaluation of Some Tear Substitutes 159
Nanostructured Drug Delivery Systems for Targeting 5-alpha-Reductase Inhibitors to the Hair Follicle 156
Aqueous ophthalmic formulations containing formocortal solubilised by surfactants or complexing agents 156
Cytotoxicity on rabbit corneal epithelial cell cultures of some polymers used as ophthalmic adjuvants 155
Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas 155
Nonpolymeric nanoassemblies for ocular administration of acyclovir: Pharmacokinetic evaluation in rabbits 155
Effect of chitosan and ts N-trimethyl and N-carboxymethyl derivatives on the ocular pharmacokinetics of ofloxacin in rabbits 154
Permeation and distribution of ferulic acid and its a-cyclodextrin complex from different formulations in hairless rat skin 154
OPHTHALMIC SOLUTIONS VISCOSIFIED WITH TAMARIND SEED POLYSACCHARIDE 151
Formulations based on natural ingredients for treatment of nail diseases 151
In vitro cutaneous permeation and distrubution of Uvinul MC80 in cosmetic formulations through hairless rat and reconstituted human skin 149
Liposome-encapsulated mitomycin-C for reduction of corneal healing rate and ocular toxicity. 149
Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid 149
Characterization and in vitro evaluation of an (ipn)-hydrogel for transdermal delivery of diltiazem. 148
Relevance of polymer molecular weight to the in vitro/in vivo performances of ocular inserts based on poly(ethylene oxide) 148
In vitro evaluation of some parameters involved in mucoadhesion of aqueous polymeric dispersions 148
Liposomes for ocular delivery of vancomicyn: preparation and in vivo evaluation 146
Arabinogalactan in the Re-Epithelization and Glycocalyx Restoration Process of Rabbit Damaged Corneas 146
Niaouli oil as enhancer for transdermal permeation of estradiol. Evaluation of gel formulations on hairless rats in vivo 146
Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert 146
Opthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization 145
Ocular bioadhesive drug delivery systems 144
Eel skin as a model substrate for mucoadhesion studies 144
Aloe purificata: formulazioni oftalmiche 143
Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome, 143
Comparison of Liposome-Encapsulated Acyclovir with Acyclovir Ointment: ocular pharmacokinetics in rabbits 143
Freeze-dried matrices for ocular administration of bevacizumab: a comparison between subconjunctival and intravitreal administration in rabbits 143
HPCH-based nail lacquers: “ex vivo” study on permeation of three antimycotics through bovine hoof membranes 142
Vehicle and enhancer effects on transdermal permeation of estradiol from gel formulations: evaluation in vitro 142
Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution 142
Combination of nanomicellar technology and in situ gelling polymer as ocular drug delivery system (Odds) for cyclosporine-a 142
Effect of chitosan on the in vitro/in vivo performances of erodible ocular inserts for the delivery of ofloxacin 141
Arabinogalactan (AG) in dry eye age-related: a new mucoadhesive and no-viscous ophthalmic vehicle with protective effect on corneal epithelium. Experimental studies. 141
Preparati oftalmici a base di polisaccaridi mucoadesivi con capacità riepitelizzante della cornea 140
Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome 140
Comparison of the effect of ultrasound and of chemical enhancers on transdermal permeation of caffeine and morphine through hairless mouse skin in vitro 140
Evaluation in rabbits of a liposomal formulation for ocular delivery of acyclovir 139
Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin 139
Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies 138
Pharmacokinetics and pressure lowering effect in rabbits of timolol in a xyloglucan vehicle 137
Terbinafine nail solutions for topical treatment of onychomycosis: Ex vivo study on penetration/retention through and into keratin membranes 136
Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines 135
Cytotoxicity evaluation of three phthalocyanine photosensitisers on human corneal epithelium cell cultures 133
Iontophoresis and Surfactants Combination on in Vitro Transungual Permeation of Nystatin 133
Nanostructured Strategies for Melanoma Treatment—Part I: Design and Optimization of Curcumin-Loaded Micelles for Enhanced Anticancer Activity 131
Nanostructured Strategies for Melanoma Treatment—Part II: Targeted Topical Delivery of Curcumin via Poloxamer-Based Thermosensitive Hydrogels 130
Preparazione e valutazione “in vitro” di formulazioni mucoadesive per uso buccale 130
Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity 129
Determination of topically applied finasteride penetrated into hair follicles by using the differential stripping technique 128
Ophthalmic vehicles containing polymer-solubilized tropicamide: "In vitro/in vivo" evaluation 127
Citotoxicity of ophthalmic adjuvants on corneal epithelium cell cultures 126
Xyloglucan as a novel vehicle for timolol: Pharmacokinetics and pressure lowering activity in rabbits 126
null 126
Ocular permeation of timolol through excised rabbit cornea and rabbit corneal epithelial cell layers: a comparison 126
Influence of polysaccharides on expression of membrane-associated muc1 in cultivated epithelial cells 125
Development and evaluation of a simple dry eye model in the albino rabbit 125
Assembling surfactants-mucoadhesive polymer nanomicelles (ASMP-nano) for ocular delivery of cyclosporine-A 125
Larch arabinogalactan for dry eye protection and treatment of corneal lesions: investigation in rabbits 124
Hydrogels as Corneal Stroma Substitutes for In Vitro Evaluation of Drug Ocular Permeation 124
New prospect in dry eye therapy: arabinogalactan, a Newtonian non-viscous lachrymal substitute. 123
Comparison of in vitro and in vivo transdermal delivery of estradiol from semisolid formulations 122
Totale 15.623
Categoria #
all - tutte 68.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.236


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.119 0 0 0 0 0 101 89 140 326 96 87 280
2021/20222.004 48 177 29 128 351 282 49 79 83 39 113 626
2022/20232.576 331 301 185 244 318 380 55 197 449 10 79 27
2023/20241.880 278 275 223 135 294 265 52 41 37 36 53 191
2024/20255.697 61 230 103 313 567 619 395 367 455 756 674 1.157
2025/20263.088 355 765 800 382 639 147 0 0 0 0 0 0
Totale 25.450